Hologic (HOLX) Receives FDA Approval for NHANES Incorporation into DXA Systems
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Join SI Premium – FREE
Hologic, Inc. (Nasdaq: HOLX) has received U.S. Food and Drug Administration (FDA) clearance to incorporate the U.S. National Health and Nutrition Examination Survey (NHANES) Whole Body Reference Data into its Discovery dual x-ray absorptiometry (DXA) systems.
The FDA clearance of the Hologic Advanced Body Composition Assessment package opens up a new market for the Hologic Discovery whole body DXA systems.
The FDA clearance of the Hologic Advanced Body Composition Assessment package opens up a new market for the Hologic Discovery whole body DXA systems.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Sky Quarry names Heidi Bowman as CFO
- Nucor (NUE) files mixed shelf
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
